Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$36.71 - $44.15 $9.88 Million - $11.9 Million
269,002 Added 91.67%
562,455 $23.4 Million
Q1 2023

Apr 18, 2023

BUY
$36.81 - $48.12 $7.57 Million - $9.9 Million
205,681 Added 234.34%
293,453 $12.1 Million
Q4 2022

Jan 12, 2023

BUY
$35.68 - $44.71 $192,993 - $241,836
5,409 Added 6.57%
87,772 $3.62 Million
Q3 2022

Oct 27, 2022

BUY
$42.51 - $54.02 $3.5 Million - $4.45 Million
82,363 New
82,363 $3.61 Million
Q4 2019

Jan 17, 2020

SELL
$60.96 - $77.7 $20.5 Million - $26.2 Million
-336,937 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$55.78 - $68.08 $18.8 Million - $22.9 Million
336,937 New
336,937 $21.4 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.